|Articles|February 22, 2017
Bio-Optronics, OmniComm to Provide Solutions for CRO
OmniComm Systems and Bio-Optromics have reached an agreement with a CRO seeking to develop cancer treatments, for the use of their EDC and CTMS solutions.
Advertisement
OmniComm Systems and Bio-Optromics have reached an agreement with a CRO seeking to develop cancer treatments, for the use of their EDC and CTMS solutions.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety
2
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
3
AI-Driven Clinical Trial Recruitment and Design
4
What Clinical Trials Can Learn from the Gig Economy About Payments
5